在心脏损伤和修复中,介质干细胞衍生长非编码RNA
Talan Tran1, Claudia Cruz1, Anthony Chan1
1Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328, USA.
Cells
|September 28, 2023
概括
介酶干细胞 (MSC) 衍生长非编码RNA (lncRNAs) 对心脏再生具有前景. 对这些非蛋白质编码RNA的进一步研究可能会导致治疗心脏损伤的新疗法.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 分子生物学分子生物学
背景情况:
- 心脏损伤,包括心肌梗塞和心力衰竭,是全球主要的健康问题.
- 成人的心脏具有有限的再生能力,阻碍了受伤后的功能恢复.
- 由于它们的分化和分泌潜力,正在研究介质干细胞 (MSC) 进行心脏再生.
研究的目的:
- 审查MSC衍生的长非编码RNAs (lncRNAs) 在心脏再生中的作用和影响.
- 探索MSC衍生的lncRNAs对心脏功能,心肌重塑,心肌细胞损伤和血管生成的影响.
- 突出MSC衍生 lncRNAs作为心血管疾病治疗点的潜力.
主要方法:
- 文献综述专注于研究MSC衍生 lncRNAs 在心脏损伤和修复的背景下.
- 分析 lncRNAs 影响心脏再生过程的分子机制.
- 综合当前关于 lncRNAs 对心脏功能和血管化的影响的知识.
主要成果:
- 从MSC衍生的lncRNAs在调节基因表达和与心脏修复相关的细胞反应方面发挥着关键作用.
- 这些lncRNAs影响心脏再生的关键方面,包括心肌细胞存活,心脏重塑和新血管的形成 (血管生成).
- 了解这些机制为心血管疾病的新疗法提供了洞察力.
结论:
- 来自MSC的lncRNAs代表了开发心脏再生的创新治疗策略的一个有希望的领域.
- 进一步的研究是必不可少的,以充分了解lncRNAs的潜力,并克服当前临床应用中的挑战.
- 阐明涉及lncRNAs的分子途径可以显著推进心脏病的治疗.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Formation of Muscle Fibers from Myoblasts
5.0K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.0K


